Repurposing the inhibitors of MMP-9 and SGLT-2 against ubiquitin specific protease 30 in Parkinson’s disease: computational modelling studies

Author:

Alshehri Mohammed M.1ORCID,Danazumi Ammar Usman23,Alshammari Mohammed Kanan4,Bello Ridwan Opeyemi5,Alghazwni Mohammed Khalid6,Alshehri Ahmed Mughram6,Alshlali Omaymah Mohammed7,Umar Haruna Isiyaku58ORCID

Affiliation:

1. Pharmaceutical Care Department, Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia

2. Faculty of Chemistry, Warsaw University of Technology, Warsaw, Poland

3. Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands

4. Department of Pharmaceutical Care, Rafha Central Hospital, Rafha, North Zone, Kingdom of Saudi Arabia

5. Computer-Aided Therapeutic Discovery and Design Group, Federal University of Technology, Akure, Nigeria

6. Pharmaceutical care Department, Security Forces Hospital - Riyadh, Riyadh, Kingdom of Saudi Arabia

7. Pharmacy Department, Abdulkarim Alhakami Medical Complex - Jazan, Jazan, Kingdom of Saudi Arabia

8. Department of Biochemistry, Federal University of Technology, Akure, Ondo State, Nigeria

Publisher

Informa UK Limited

Subject

Molecular Biology,General Medicine,Structural Biology

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3